Lars Johansson Selected Research

Lars Johansson Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2008
14	Body Weight (Weight, Body) 01/2022 - 10/2002
9	Neoplasms (Cancer) 11/2020 - 09/2003
9	Myocardial Infarction 02/2017 - 01/2002
8	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
8	Stroke (Strokes) 03/2021 - 08/2005
7	Hemorrhage 12/2016 - 06/2007
6	Obesity 04/2020 - 04/2004
5	Cerebral Hemorrhage 11/2020 - 04/2004
5	Ischemic Stroke 01/2017 - 08/2005
4	Cicatrix (Scar) 02/2017 - 07/2009
3	Weight Loss (Weight Reduction) 01/2022 - 01/2011
3	Fatty Liver 11/2021 - 12/2019
3	Hypertension (High Blood Pressure) 01/2020 - 01/2017
3	Insulin Resistance 01/2019 - 12/2008
3	Hemorrhagic Stroke 01/2017 - 02/2002
3	Atrial Fibrillation 12/2016 - 10/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2010
3	Inflammation (Inflammations) 06/2014 - 12/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 08/2004 - 08/2002
2	Overweight 12/2019 - 11/2018
2	Heart Failure 01/2019 - 05/2011
2	Infarction (Infarctions) 03/2017 - 02/2015
2	Infections 03/2016 - 03/2012
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016 - 05/2012
2	Death (Near-Death Experience) 01/2016 - 05/2013
2	Insulinoma 07/2014 - 05/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2014 - 01/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014 - 05/2008
2	Atherosclerosis 12/2012 - 10/2007
2	Coronary Disease (Coronary Heart Disease) 10/2007 - 03/2006
2	Coronary Occlusion 07/2006 - 08/2004
1	Fibrosis (Cirrhosis) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2012
7	AnticoagulantsIBA 01/2017 - 07/2009
6	dapagliflozinIBA 01/2022 - 03/2012
6	EnzymesIBA 11/2021 - 12/2012
6	Warfarin (Coumadin)FDA LinkGeneric 12/2016 - 06/2007
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
5	von Willebrand FactorIBA 11/2020 - 02/2002
5	Blood Glucose (Blood Sugar)IBA 03/2017 - 06/2010
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 05/2014
4	Protons (Proton)IBA 01/2022 - 04/2020
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 05/2014
4	CholesterolIBA 01/2018 - 06/2014
4	GadoliniumIBA 02/2017 - 07/2006
4	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 05/2014
4	C-Reactive ProteinIBA 02/2015 - 10/2007
4	Contrast MediaIBA 07/2006 - 10/2002
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2012
3	Triglycerides (Triacylglycerol)IBA 04/2020 - 12/2012
3	LipidsIBA 04/2020 - 01/2015
3	Dihydroorotate DehydrogenaseIBA 01/2020 - 01/2018
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 03/2012
3	Insulin (Novolin)FDA Link 12/2018 - 06/2010
3	AntigensIBA 11/2015 - 07/2009
3	Troponin IIBA 02/2015 - 05/2011
3	Exenatide (Byetta)FDA Link 01/2015 - 05/2014
3	manganese chloride (manganese chloride, tetrahydrate)FDA Link 04/2014 - 05/2004
3	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2012 - 01/2002
3	ThrombomodulinIBA 07/2009 - 02/2002
3	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 08/2004 - 10/2002
2	glimepiride (Amarel)FDA LinkGeneric 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2020
2	saxagliptin FDA Link 01/2022 - 01/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2021 - 07/2014
2	Factor XII (Hageman Factor)IBA 03/2021 - 01/2017
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2021 - 10/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2019 - 03/2006
2	Sodium-Glucose Transport ProteinsIBA 01/2019 - 03/2012
2	Carboxylic AcidsIBA 11/2018 - 01/2018
2	fibrin fragment D (D-dimer)IBA 01/2018 - 05/2014
2	LDL CholesterolIBA 03/2017 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2017 - 12/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2016 - 05/2013
2	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2015 - 05/2011
2	Cystatin CIBA 02/2015 - 08/2013
2	pro-brain natriuretic peptide (1-76)IBA 02/2015 - 05/2011
2	Parathyroid Hormone (Parathormone)IBA 11/2014 - 07/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014 - 01/2007
2	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 04/2014 - 05/2004
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2012 - 08/2005
2	Lipoproteins (Lipoprotein)IBA 12/2012 - 05/2012
2	IronIBA 01/2007 - 10/2002
1	Glucagon (Glukagon)FDA Link 01/2022
1	IncretinsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	semaglutideIBA 11/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021
1	omega-3 carboxylic acidIBA 01/2021
1	NucleotidesIBA 11/2020
1	ABO Blood-Group SystemIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020

Therapy/Procedure

4	Therapeutics 10/2020 - 01/2018
3	Glycemic Control 01/2022 - 03/2012
2	Drug Therapy (Chemotherapy) 11/2020 - 09/2003